CAC Software vs ClearRead CT
AI Verdict
Choose CAC Software if…
Choose Imbio's CAC Software if your primary focus is a highly specialized, in-depth quantification and visualization of coronary artery calcification from non-contrast chest CTs. This tool excels at providing detailed metrics like Agatston score, arterial age, and 3D visualizations specifically for cardiac risk assessment. It is ideal when the main objective is a comprehensive analysis of coronary calcification.
View CAC Software →Choose ClearRead CT if…
Choose Riverain Technologies' ClearRead CT if you require a comprehensive AI suite for both pulmonary nodule detection and coronary artery calcification analysis within a single workflow. This tool is ideal for improving overall diagnostic accuracy and reducing reading times across cardiothoracic CTs, leveraging features like patented vessel suppression for enhanced nodule visibility and automated nodule tracking.
View ClearRead CT →When choosing between Imbio’s CAC Software and Riverain Technologies’ ClearRead CT, physicians should consider their primary diagnostic focus. Imbio’s CAC Software excels in comprehensive coronary artery calcification analysis, providing detailed quantification including Agatston score, arterial age, calcified lesion mass, and volume, along with 3D visualizations. It is specifically designed for cardiologists and radiologists focused on cardiovascular risk assessment from non-contrast chest CTs. Its deep-learning based analysis integrates seamlessly into existing DICOM workflows, making it ideal for practices prioritizing in-depth cardiac calcification assessment.
In contrast, ClearRead CT offers a broader AI suite for cardiothoracic health, with a strong emphasis on pulmonary nodule detection alongside CAC analysis. Its patented vessel suppression technology and features for nodule characterization, measurement, and automated tracking make it particularly valuable for pulmonologists and radiologists managing lung cancer screening and follow-up. The key practical difference lies in ClearRead CT’s dual focus and proven ability to reduce reading times and improve nodule detection accuracy. Therefore, a physician whose practice involves a significant volume of lung nodule evaluations in addition to cardiac risk assessment would likely find ClearRead CT more beneficial, while a practice solely focused on detailed coronary artery calcification analysis would be better served by Imbio’s specialized CAC Software.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CAC Software | ClearRead CT |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Cloud, On-premise, Partner platforms | On-premise (stand-alone server, virtual machine) and Cloud |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CAC Software | ClearRead CT |
|---|---|---|
| Tool Name | CAC Software | ClearRead CT |
| Company | Imbio | RIVERAIN TECHNOLOGIES |
| Primary Focus | Automated image post-processing for coronary artery calcification analysis from non-contrast chest CT. | AI suite for pulmonary nodule detection and coronary artery calcification analysis in CT scans. |
| CAC Scoring Details | Outputs Agatston score, arterial age, calcified lesion mass and volume; provides 3D visualizations and annotated images. | Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs). |
| Other Key Functionality | Deep-learning based analysis; integrates into existing DICOM viewing workflow. | Pulmonary Nodule Detection (solid, part-solid, ground glass); Patented Vessel Suppression; Nodule Characterization and Measurement; Automated Nodule Tracking. |
| Supported Specialties | Cardiology, Radiology | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring CAC Software and ClearRead CT.